News and Announcements
Most Active Venture Capital Funds in Israel – 2016
- Published March 06, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
UpWest Labs, Singulariteam & OurCrowd Funds Top the List of Most Active VC Funds in 2016.
IVC Research Centre, in collaboration with Israeli law firm AMP & Co., have recently released a report analysing first investments in Israel by venture capital funds in the past five years, ranking the most active venture capital in Israel in 2016.
Ranking top places from 2016’s Most Active VC Funds Ranking are three VC funds, each having successfully completed eight first investments in 2016. While all three are considered early stage, low-placement, small funds and their new portfolio strategies in 2016 were varied.
For more details, please download the supporting document.
Company Updates
The Biofilm Breakthrough: How An Australian BioTech Firm Is Tapping Indonesia’s $45,000-a-Kitchen Bottleneck
Australian sustainability and deep-tech firm Altair International Pty Ltd is commercialising plant-based clinical hygiene technology, targeting a prime operational bottleneck in Indonesia’s massive national free meals program. Every few years, an Australian deep-tech company emerges combining proprietary science with a transformational anchor contract, the kind of business that quietly creates an entirely new market category […]
THE TAX CHANGED. NOW THE PRODUCT IS CHANGING TO MATCH.
Changes to the 50% capital gains tax discount are shifting Australian private capital away from growth and into high-yielding wrappers. Fund managers are actively redesigning products across private credit and property to capture the incoming capital rotation
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.
Backed By Leading Investment Groups and Family Offices
